Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.89% | 33.45 | 0.9% | $1134.85m | |
| JNJ | Johnson & Johnson | -0.59% | 142.42 | 0.7% | $1072.66m | |
| BMY | Bristol-Myers Squibb Co. | -2.42% | 58.12 | 1.0% | $943.99m | |
| MRK | Merck & Co., Inc. | -1.57% | 76.70 | 0.7% | $803.90m | |
| ABBV | AbbVie, Inc. | -1.29% | 98.00 | 2.3% | $774.89m | |
| LLY | Eli Lilly & Co. | -1.60% | 166.42 | 1.1% | $684.88m | |
| AZN | AstraZeneca Plc | -0.39% | 53.98 | 1.2% | $288.95m | |
| VXRT | Vaxart, Inc. | 0.49% | 8.19 | 0.0% | $287.88m | |
| RPRX | Royalty Pharma Plc | 0.71% | 48.36 | 0.1% | $228.11m | |
| NVS | Novartis AG | -0.86% | 87.36 | 0.2% | $150.20m | |
| RGEN | Repligen Corp. | 2.71% | 128.67 | 7.2% | $120.40m | |
| GSK | GlaxoSmithKline Plc | -0.96% | 40.34 | 0.2% | $111.37m | |
| NVO | Novo Nordisk A/S | -0.43% | 65.60 | 0.1% | $93.80m | |
| RETA | Reata Pharmaceuticals, Inc. | -1.19% | 156.12 | 3.4% | $81.15m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -2.71% | 75.84 | 0.0% | $71.31m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.